Advisor Group, Inc. - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2019$16,000
+6.7%
150.0%0.00%
Q3 2019$15,000
-6.2%
150.0%0.00%
Q2 2019$16,000
-5.9%
150.0%0.00%
Q1 2019$17,000
+6.2%
150.0%0.00%
Q4 2018$16,000
-5.9%
15
+7.1%
0.00%
Q3 2018$17,0000.0%140.0%0.00%
Q2 2018$17,000
+30.8%
14
+16.7%
0.00%
Q1 2018$13,000
-7.1%
120.0%0.00%
Q4 2017$14,0000.0%120.0%0.00%
Q4 2016$14,0000.0%120.0%0.00%
Q3 2016$14,000
+7.7%
12
-7.7%
0.00%
Q2 2016$13,000130.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2017
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 6,195,000$9,377,0002.84%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,000,000$10,750,0001.09%
Man Investments (CH) AG 1,100,000$1,482,0000.73%
ADVENT CAPITAL MANAGEMENT /DE/ 22,554,000$30,444,0000.47%
SSI INVESTMENT MANAGEMENT LLC 3,124,000$4,202,0000.45%
ARROWGRASS CAPITAL PARTNERS (US) LP 20,000$22,373,0000.42%
Calamos Advisors LLC 35,219,000$47,628,0000.33%
LINDEN ADVISORS LP 2,500,000$3,370,0000.23%
Calamos Wealth Management LLC 513,000$694,0000.17%
LOOMIS SAYLES & CO L P 477,810$50,323,0000.15%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders